Conference Proceedings

Efficacy of a Third Course of Alemtuzumab in Patients with Active Relapsing-Remitting Multiple Sclerosis Who Experienced Disease Activity After the Initial Two Courses: Pooled Analysis of CARE-MS I and II

HJ Kim, A Traboulsee, A Boster, AD Bass, R Berkovich, G Comi, O Fernandez, V Limmroth, J Lycke, R Al Macdonell, B Sharrack, P Vermersch, H Wiendl, T Ziemssen, M Melanson, N Daizadeh, BA Singer

MULTIPLE SCLEROSIS JOURNAL | SAGE PUBLICATIONS LTD | Published : 2018